107 related articles for article (PubMed ID: 38638970)
21. Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders.
Bhattacharya T; Soares GABE; Chopra H; Rahman MM; Hasan Z; Swain SS; Cavalu S
Materials (Basel); 2022 Jan; 15(3):. PubMed ID: 35160749
[TBL] [Abstract][Full Text] [Related]
22. Neuropathological Mechanisms of β-N-Methylamino-L-Alanine (BMAA) with a Focus on Iron Overload and Ferroptosis.
Kazemi Shariat Panahi H; Dehhaghi M; Heng B; Lane DJR; Bush AI; Guillemin GJ; Tan VX
Neurotox Res; 2022 Apr; 40(2):614-635. PubMed ID: 35023054
[TBL] [Abstract][Full Text] [Related]
23. Dysregulation of Iron Homeostasis in the Central Nervous System and the Role of Ferroptosis in Neurodegenerative Disorders.
David S; Jhelum P; Ryan F; Jeong SY; Kroner A
Antioxid Redox Signal; 2022 Jul; 37(1-3):150-170. PubMed ID: 34569265
[No Abstract] [Full Text] [Related]
24. A Bibliometric Analysis of Pyroptosis From 2001 to 2021.
Ma D; Yang B; Guan B; Song L; Liu Q; Fan Y; Zhao L; Wang T; Zhang Z; Gao Z; Li S; Xu H
Front Immunol; 2021; 12():731933. PubMed ID: 34484243
[TBL] [Abstract][Full Text] [Related]
25. Impacts of Iron Metabolism Dysregulation on Alzheimer's Disease.
Jouini N; Saied Z; Ben Sassi S; Nebli F; Messaoud T; Hentati F; Belal S
J Alzheimers Dis; 2021; 80(4):1439-1450. PubMed ID: 33682709
[TBL] [Abstract][Full Text] [Related]
26. Bibliometric Analysis of the Inflammasome and Pyroptosis in Brain.
Chen Y; Li Y; Guo L; Hong J; Zhao W; Hu X; Chang C; Liu W; Xiong K
Front Pharmacol; 2020; 11():626502. PubMed ID: 33551822
[No Abstract] [Full Text] [Related]
27. Ferroptosis: mechanisms and links with diseases.
Yan HF; Zou T; Tuo QZ; Xu S; Li H; Belaidi AA; Lei P
Signal Transduct Target Ther; 2021 Feb; 6(1):49. PubMed ID: 33536413
[TBL] [Abstract][Full Text] [Related]
28. System Xc
Liu MR; Zhu WT; Pei DS
Invest New Drugs; 2021 Aug; 39(4):1123-1131. PubMed ID: 33506324
[TBL] [Abstract][Full Text] [Related]
29. Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory.
Li X; Zhang J; Li D; He C; He K; Xue T; Wan L; Zhang C; Liu Q
Neuron; 2021 Mar; 109(6):957-970.e8. PubMed ID: 33503410
[TBL] [Abstract][Full Text] [Related]
30. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease.
Bao WD; Pang P; Zhou XT; Hu F; Xiong W; Chen K; Wang J; Wang F; Xie D; Hu YZ; Han ZT; Zhang HH; Wang WX; Nelson PT; Chen JG; Lu Y; Man HY; Liu D; Zhu LQ
Cell Death Differ; 2021 May; 28(5):1548-1562. PubMed ID: 33398092
[TBL] [Abstract][Full Text] [Related]
31. Ferroptosis: molecular mechanisms and health implications.
Tang D; Chen X; Kang R; Kroemer G
Cell Res; 2021 Feb; 31(2):107-125. PubMed ID: 33268902
[TBL] [Abstract][Full Text] [Related]
32. Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.
Reichert CO; de Freitas FA; Sampaio-Silva J; Rokita-Rosa L; Barros PL; Levy D; Bydlowski SP
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233496
[TBL] [Abstract][Full Text] [Related]
33. Ferroptosis Mediates Cuprizone-Induced Loss of Oligodendrocytes and Demyelination.
Jhelum P; Santos-Nogueira E; Teo W; Haumont A; Lenoël I; Stys PK; David S
J Neurosci; 2020 Nov; 40(48):9327-9341. PubMed ID: 33106352
[TBL] [Abstract][Full Text] [Related]
34. FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Disease.
Tian Y; Lu J; Hao X; Li H; Zhang G; Liu X; Li X; Zhao C; Kuang W; Chen D; Zhu M
Neurotherapeutics; 2020 Oct; 17(4):1796-1812. PubMed ID: 32959272
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of AMPK Ameliorates Alzheimer's Disease-Like Tau Pathology and Memory Impairment.
Wang L; Li N; Shi FX; Xu WQ; Cao Y; Lei Y; Wang JZ; Tian Q; Zhou XW
Mol Neurobiol; 2020 Aug; 57(8):3349-3361. PubMed ID: 32519244
[TBL] [Abstract][Full Text] [Related]
36. Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis.
Plascencia-Villa G; Perry G
Antioxid Redox Signal; 2021 Mar; 34(8):591-610. PubMed ID: 32486897
[No Abstract] [Full Text] [Related]
37. The Application of Ferroptosis in Diseases.
Qiu Y; Cao Y; Cao W; Jia Y; Lu N
Pharmacol Res; 2020 Sep; 159():104919. PubMed ID: 32464324
[TBL] [Abstract][Full Text] [Related]
38. The Chemistry and Biology of Ferroptosis.
Stockwell BR; Jiang X
Cell Chem Biol; 2020 Apr; 27(4):365-375. PubMed ID: 32294465
[TBL] [Abstract][Full Text] [Related]
39. Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer's disease: Evidence of ferroptosis.
Ashraf A; Jeandriens J; Parkes HG; So PW
Redox Biol; 2020 May; 32():101494. PubMed ID: 32199332
[TBL] [Abstract][Full Text] [Related]
40. Brain iron deposition is linked with cognitive severity in Parkinson's disease.
Thomas GEC; Leyland LA; Schrag AE; Lees AJ; Acosta-Cabronero J; Weil RS
J Neurol Neurosurg Psychiatry; 2020 Apr; 91(4):418-425. PubMed ID: 32079673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
